Ironwood Pharmaceuticals Quote - IRWD

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

3.69

Bid

3.36

Ask

4.10

Volume

0.00 Day's Range 0.00

3.06 52 Week Range 15.70

Market Cap

590.505M

Previous Close

3.69

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

1,552,906

Shares Outstanding

160,028,388

Dividend Yield

PE Ratio

-0.59

Earnings Per Share (EPS)

-6.26

Revenue

442.74M

Net Profit

-1B

Ironwood Pharmaceuticals is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing innovative product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic const... Ironwood Pharmaceuticals is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing innovative product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.ironwoodpharma.com

Headquarters

Wilmington, Delaware, USA

Founded

Ironwood Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker IRWD. The last closing price for Ironwood Pharmaceuticals was US$3.69. Over the last year, Ironwood Pharmaceuticals shares have traded in a share price range of US$ 3.06 to US$ 15.70.

Ironwood Pharmaceuticals currently has 160,028,388 shares outstanding. The market capitalization of Ironwood Pharmaceuticals is US$590.50 million. Ironwood Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.59.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.115	3.21678321678	3.575	4.05	3.06	2162512	3.65280292	CS
4	-0.63	-14.5833333333	4.32	4.41	3.06	1763341	3.63494806	CS
12	-0.86	-18.9010989011	4.55	5.05	3.06	1552906	4.05142601	CS
26	-2.71	-42.34375	6.4	7.105	3.06	1880616	4.92879301	CS
52	-6.58	-64.0701071081	10.27	15.7	3.06	2796493	8.30032964	CS
156	-7.32	-66.485013624	11.01	15.7	3.06	2526101	9.95897618	CS
260	-8.69	-70.1938610662	12.38	15.7	3.06	2279699	10.38441816	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
PALIPalisade Bio Inc	US$ 2.95 (110.71%)	9.53M
DBVTDBV Technologies SA	US$ 4.34 (31.91%)	2.52M
AMPGAmplitech Group Inc	US$ 2.46 (27.46%)	10.18M
CTHRCharles and Colvard Ltd	US$ 1.96 (24.83%)	1.19M
WHLRWheeler Real Estate Investment Trust Inc	US$ 5.56 (24.66%)	1.07M
PNBKPatriot National Bancorp Inc	US$ 1.08 (-58.78%)	13
SPGCSacks Parente Golf Inc	US$ 0.58 (-58.57%)	41.23k
KROSKeros Therapeutics Inc	US$ 40.50 (-41.01%)	9.58k
AVGRAvinger Inc	US$ 0.50 (-39.02%)	36.36k
HEPAHepion Pharmaceuticals Inc	US$ 0.36 (-38.46%)	1
AMPGAmplitech Group Inc	US$ 2.47 (27.98%)	10.18M
PALIPalisade Bio Inc	US$ 2.94 (110.00%)	9.53M
RGTIRigetti Computing Inc	US$ 6.69 (-9.35%)	3.14M
RZLVRezolve AI Ltd	US$ 2.19 (10.05%)	2.91M
SVMHSRIVARU Holding Ltd	US$ 0.0273 (-0.36%)	2.71M